Deborah Wong

11PUBLICATIONS
112CO-AUTHORS
Predictive and prognostic markersCancer diagnosisAllergyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 19, 2026
Danvatirsen plus Pembrolizumab versus Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (PEMDA-HN): A Randomized, Phase II Trial.

|May 08, 2026
Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial.

|Dec 04, 2025
Evolving Use of Circulating Tumor DNA for HPV+ Oropharyngeal Carcinoma: Consensus Recommendations From the California Head and Neck Consortium.

Allen S Ho, Justin T Moyers, Shirin Attarian

|Jun 11, 2025
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas.

Kevin J Harrington, Stephane Champiat, Joshua D Brody

|May 28, 2025
A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck.

|Sep 14, 2024
Therapeutic Advances in Advanced Basal Cell Carcinoma.

Samer Alkassis, Maya Shatta, Deborah J Wong

Pageof 2

Frequent Collaborators

2 joint publications

Emrullah Yilmaz

2 joint publications

Nabil F Saba

2 joint publications

Kevin J Harrington

2 joint publications

Sung-Bae Kim